BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 28397711)

  • 1. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS.
    Das MK; Bishwal SC; Das A; Dabral D; Varshney A; Badireddy VK; Nanda R
    Anal Chem; 2014 Jan; 86(2):1229-37. PubMed ID: 24350824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury.
    Bos LD; van Walree IC; Kolk AH; Janssen HG; Sterk PJ; Schultz MJ
    J Appl Physiol (1985); 2013 Nov; 115(10):1487-95. PubMed ID: 23908314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing patterns of volatile organic compounds exhaled in breath after consumption of two infant formulae with a different lipid structure: a randomized trial.
    Smolinska A; Baranska A; Dallinga JW; Mensink RP; Baumgartner S; van de Heijning BJM; van Schooten FJ
    Sci Rep; 2019 Jan; 9(1):554. PubMed ID: 30679671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
    Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
    J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
    Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
    Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
    Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
    Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
    Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
    J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How long may a breath sample be stored for at  -80 °C? A study of the stability of volatile organic compounds trapped onto a mixed Tenax:Carbograph trap adsorbent bed from exhaled breath.
    Kang S; Paul Thomas CL
    J Breath Res; 2016 Jun; 10(2):026011. PubMed ID: 27272219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.